Idiopathic Pulmonary Fibrosis | Lung Foundation Australia

We know that people with a rare disease, such as Idiopathic Pulmonary Fibrosis (IPF) face very similar problems including:

A delay in diagnosis and treatment due to limited awareness of their condition
Difficulty accessing information, the best service and treatment, either because of locality or because one does not exist
Difficulty navigating the health system and accessing support, whether this is in the form of equipment, financial or peer support.

Lung Foundation Australia is working to fill these gaps through a range of resources and initiatives.

Research

We are committed to driving dedicated research that will help improve the health outcomes and quality of life for those affected by IPF. Our research program includes a world renowned IPF registry, clinical trials group and a suite of IPF research awards and grants available to researchers and health professionals.

Treatment & models of care

Idiopathic Pulmonary Fibrosis

Immune regulation of Idiopathic Pulmonary Fibrosis

Treatment & models of care

Idiopathic Pulmonary Fibrosis

Identification of Perfenidone - responsive patients with IDF by high-throughput in-vitro screening.

Detection & diagnostics

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease

Novel diagnostic techniques in Interstitial Lung Disease.

Information and Support Centre

Our Information and Support Centre team provides guidance, information and support, and connects people to relevant and valuable Lung Foundation Australia and community support services. This free and confidential service is available Monday to Friday 8am – 4.30pm (AEST) (excl. public holidays). Please note that this service does not offer medical or treatment advice.